Programs and Research

Center of Excellence for Liver and Digestive Health (CELDH)

The Center of Excellence for Liver and Digestive Health (CELDH), a key initiative by AILDD, is a pioneering program established to elevate the standards of healthcare for liver and digestive diseases in Africa.

This center serves as a hub for advanced medical research, patient care, and professional training, integrating cutting-edge technology and evidence-based practices.

By fostering collaborations with global experts and local communities, CELDH aims to revolutionize treatment approaches, enhance patient education, and build a network of skilled healthcare professionals, making significant strides towards a future where liver and digestive health issues are effectively managed and ultimately eradicated in African communities.

Africa HepatoPancreatoBiliary Cancer Consortium (AHPBCC)

The Africa HepatoPancreatoBiliary Cancer Consortium (AHPBCC), initiated by AILDD, is a groundbreaking program dedicated to combating hepato-pancreato-biliary (HPB) cancers in Africa.

This consortium unites experts from across the continent and globally to foster research, advance treatment strategies, and improve patient outcomes for these complex and deadly cancers.

Focusing on innovation, education, and collaborative efforts, AHPBCC is committed to transforming the landscape of HPB cancer care in African communities, prioritizing culturally sensitive approaches and evidence-based practices to meet the unique healthcare challenges of the region.

Biorepository/GWAS

The Biorepository/Genome-Wide Association Studies (GWAS) program is a cutting-edge initiative designed to revolutionize the understanding and treatment of genetic and complex diseases.

This program involves the collection and storage of biological samples in a biorepository, creating a comprehensive database that supports large-scale genetic analysis through GWAS.

By examining the genetic variations across diverse populations, the program aims to identify genetic markers associated with various diseases, paving the way for personalized medicine and targeted therapies.

This initiative not only enhances the capability for groundbreaking research but also fosters collaborations among scientists globally, contributing significantly to the advancement of medical science and the improvement of patient outcomes.

Center of Excellence for Liver and Digestive Health (CELDH)

The Ghana HCV Program is an innovative and comprehensive initiative focused on tackling Hepatitis C, a significant public health challenge in Ghana. This program is dedicated to the eradication of Hepatitis C through a multi-faceted approach that includes widespread screening, public education, and access to effective treatment. By leveraging the latest in medical research and partnering with local healthcare providers, the program aims to increase awareness, reduce transmission rates, and improve treatment outcomes for individuals affected by Hepatitis C. Emphasizing prevention, early detection, and state-of-the-art care, the Ghana HCV Program represents a crucial step towards a Hepatitis C-free future in Ghana, ultimately contributing to the overall improvement of liver health in the region.

Ghana HCV Program

The Ghana HCV Program, spearheaded by health-focused organizations, is a landmark initiative aimed at combating Hepatitis C, a major health concern in Ghana.

This program employs a comprehensive strategy that includes extensive public education, large-scale screening, and providing access to the latest treatment options.

Focused on reducing the prevalence of Hepatitis C, the initiative is grounded in community engagement, awareness campaigns, and strengthening healthcare systems for effective management and treatment of the virus.

By prioritizing early detection and advanced care, the Ghana HCV Program is committed to significantly decreasing Hepatitis C transmission and enhancing the quality of life for affected individuals, marking a pivotal step towards eradicating this disease in Ghana.

Ghana Hepatitis and Liver Cancer Study

The Ghana Hepatitis and Liver Cancer Study program is a comprehensive research initiative designed to address the growing concern of hepatitis infections and their progression to liver cancer in Ghana.

This program combines epidemiological studies, public health interventions, and advanced medical research to understand the patterns, causes, and effects of hepatitis and liver cancer within the Ghanaian population.

By integrating data collection, analysis, and community outreach, the program aims to develop effective prevention strategies, improve diagnostic methods, and enhance treatment protocols.

This proactive approach not only seeks to reduce the incidence of hepatitis and liver cancer in Ghana but also contributes significantly to the global body of knowledge on these critical health issues, ultimately leading to better health outcomes and increased awareness within the community.

Somali Health Advisory Committee (SHAC)

The Somali Health Advisory Committee (SHAC) is an innovative and collaborative initiative focused on improving healthcare outcomes for the Somali community in the United States.

Recognizing the unique health challenges and cultural needs of this population, SHAC serves as a platform for dialogue, advocacy, and action between healthcare providers, community leaders, and Somali individuals.

The committee’s mission is to bridge gaps in healthcare accessibility and understanding, fostering culturally sensitive health programs and policies.

Through community engagement, education, and research, SHAC aims to enhance overall health literacy, promote preventive care, and address specific health concerns prevalent in the Somali community.

This program is a testament to the power of community-centered approaches in addressing health disparities and advancing equitable healthcare solutions.

Your Contribution Makes a Difference

At AILDD, we believe in the power of collective action to bring about significant change. We invite you to join us in our relentless pursuit to combat liver and digestive diseases in African communities. By getting involved with AILDD, you become a part of a global movement dedicated to transforming healthcare in Africa. Every action, no matter the size, contributes to a brighter, healthier future. Together, we can make a world of difference.

Scroll to Top